Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD

Study of Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With Nonalcoholic Fatty Liver Disease

This study aims to examine the link between Non-Alcoholic Fatty Liver Disease (NAFLD) and cardiovascular diseases by studying the association between liver fibrosis degree and cardiovascular risk factors. The study would clarify the value and the role of the Coronary calcium score (CAC score) in the screening for coronary disease in this population at high cardiovascular risk.

Hepatic Fibrosis and Cardiovascular Risk are evaluated by non invasive tests

Inclusion Criteria:

• NAFLD patients regardless of disease stage of severity (from simple steatosis to cirrhosis)
• Patient without known heart disease
• Patient agreeing to participate and who has given his non opposition

Exclusion Criteria:

• Association with another cause of liver disease
• Already known coronary artery disease
• Pregnancy or breastfeeding in progress